Fetal growth in women managed with insulin pump therapy compared to conventional insulin.

  title={Fetal growth in women managed with insulin pump therapy compared to conventional insulin.},
  author={Dawn Kernaghan and Tom Farrell and Peter Hammond and Philip Owen},
  journal={European journal of obstetrics, gynecology, and reproductive biology},
  volume={137 1},
OBJECTIVE Fetal hyperinsulinaemia secondary to maternal hyperglycaemia is considered to be the driving force behind excessive fetal growth. We hypothesised that insulin pump therapy (continuous subcutaneous insulin infusion, CSII) would improve maternal glycaemic control and normalise fetal growth parameters. To this end, this study compares maternal glycaemic control and fetal growth of women receiving insulin pump therapy with those receiving conventional insulin therapy. STUDY DESIGN… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 10 extracted citations

Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists • 2014
View 1 Excerpt

Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: a case-control study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology • 2010

Similar Papers

Loading similar papers…